Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy

E-ISSN： 1873-5592|3|6|465-482

ISSN： 1389-4501

Source： Current Drug Targets, Vol.3, Iss.6, 2002-12, pp. : 465-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Chemoprevention Drug Targets

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 45-54

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

By Marin Jose J. G. Sanchez de Medina Fermin Castaño Beatriz Bujanda Luis Romero Marta R. Martinez-Augustin Olga Moral-Avila Rosario Del Briz Oscar

Drug Metabolism Reviews, Vol. 44, Iss. 2, 2012-05 ,pp. : 148-172

Informa Healthcare

Access to resources Recommend Favorite

From chemoprevention to chemotherapy: common targets and common goals

By Aggarwal Bharat B Takada Yasunari Oommen Oommen V

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1327-1338

Informa Healthcare

Access to resources Recommend Favorite

HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention

Current Molecular Pharmacology, Vol. 4, Iss. 1, 2011-01 ,pp. : 62-77

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeres and telomerase: targets for cancer chemotherapy?

By Perry P.J. Kelland L.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1567-1586

Informa Healthcare

Access to resources Recommend Favorite